ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations, announced today that it supports the recent American College of Obstetricians and Gynecologists (ACOG) Committee on Ethics Opinion (Opinion No. 395, January 2008) entitled “Surgery and Patient Choice.” The Opinion recognizes growing patient autonomy, and acknowledges that “increased patient access to information has prompted more patient-generated requests for surgical interventions not necessarily recommended by their physicians.”
